Healthtech Series B Investors & VC Firms
1027 firms in this list, with a median first check of $540K. 256 of them lead rounds. Generated from verified public data and updated continuously.
Y Innovations
CambridgeSeed–Series B
1 person
YFY Biotech Management Company
TaipeiSeed–Series B
1 person
BDC Thrive Venture Fund for Women
MontréalSeed–Series B
HAWK Family Office
LondonSeed–Series B
Mithera Capital
SeattleSeed–Late Stage
One Capital
TokyoSeed–Growth
Scale-Up Ventures
Pre-Seed–Series B$100K – $250K
2 people
1521 Ventures
San FranciscoSeed–Late Stage
1 person
Jacket River Capital Partners
BostonSeed–Late Stage
1 person
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
Experior Venture Fund
WarsawSeed–Series B$216K – $3.2M
3 people
12/12 Ventures
SausalitoSeed–Series B
1 person
Finnish Fund for Industrial Cooperation Ltd. (FINNFUND)
HelsinkiSeries B
1 person
IGC - Innovative Growth Capital
San FranciscoSeed–Growth
1 person
Kern Venture Group
Kern CountyPre-Seed–Series B
1 person
Nissay Capital
TokyoPre-Seed–Growth
1 person
Aflac Ventures Japan
TokyoSeed–Growth
7 people
Solus Capital
BudapestSeed–Late Stage$32.4K – $4.3M
4 people
EMBRAPII
BrasíliaPre-Seed–Growth
Equitane
Seed–Growth
Impact Ventures PSM
Seed–Growth
Stonebridge Ventures
SeoulSeries A–Series C
3 people
The Wells Investment
SeoulSeed–Late Stage
Wai Mohala Ventures SPV 1
Pre-Seed–Series B
Related lists
Healthtech Investors & VC Firms (4190)Healthtech Seed Investors & VC Firms (3233)Series B Investors & VC Firms (2946)Healthtech Investors & VC Firms in North America (2665)Healthtech Investors & VC Firms in United States (2436)Healthtech Series A Investors & VC Firms (2309)Series B Investors & VC Firms in North America (1736)Series B Investors & VC Firms in United States (1571)Healthtech Pre-Seed Investors & VC Firms (1468)Healthtech Investors & VC Firms in Europe (1357)
Data sourced from public filings and firms' own websites — see our methodology.









